Skip to main content

Table 1 Descriptive statistics of 41 patients treated with CLZ

From: Clozapine and desmethylclozapine: correlation with neutrophils and leucocytes counting in Mexican patients with schizophrenia

Parameters

N

Mean ± SE

Median (range)

Age (years)

 Male

22 (53.7%)

34.68 ± 1.58

36 (23–50)

 Female

19 (46.3%)

31.58 ± 1.29

35 (26–43)

CLZ time (months)

 Male

 

10.05 ± 1.74

10 (1–32)

 Female

 

6.63 ± 1.15

6 (1–24)

CLZ dose (mg/day)

 Male

 

222.73 ± 42.95

150 (100–900)

 Female

 

105.26 ± 8.46

100 (50–200)

CLZ levels (ng/mL)

 Male

 

290.11 ± 51.56

203.25 (44–846)

 Female

 

336.36 ± 29.16

321.77 (91–572)

DMC levels (ng/mL)

 Male

 

134.98 ± 12.78

108.93 (28–308)

 Female

 

127.17 ± 16.91

133.78 (47–245)

  

Number of subjects (percentage)

 

Tobacco smokers

 

12.2% (n = 5)

 

Marijuana smokers

 

4.9% (n = 2)

Drink alcohol (alcoholism)

 

7.3% (n = 3)

Drink coffee

 

14.6% (n = 6)